Interestingly, we found that the mutation frequency of TP53 in ESCC tumors and PNM was significantly higher than that in the GC group, consistent with the high incidence of TP53 mutations in ESCC reported by other studies (36). The gene discussed is TP53; the disease is esophageal squamous cell carcinoma.